Su, Muh-Hwan (Sinopharm 201512 General Manager of SynCore Biotechnology Co Ltd) |
Chief Executive Officer (CEO) |
Sinphar Pharmaceutical (Group) |
Taiwan |
Su, Stanley (B Braun 201807 Managing Director Greater China) |
Managing Director |
B. Braun (Group) |
China |
Subkowski, Thomas (BASF 200808) |
n. a. |
BASF (Group) |
Germany |
Subramanian, Romesh (201904 CEO before RaNa Therapeutics + Alexion Pharmaceuticals) |
Chief Executive Officer (CEO) |
Dyne Therapeutics Inc. |
United States (USA) |
Subramanian, Vandana (Sayre Therapeutics 201604 Head of Business Development) |
Business Development Manager / Strategy Manager |
Sayre Therapeutics Pvt. Ltd. |
India |
Suckau, Detlev (Bruker Corp 200803 Bruker Daltonics Head Proteomics RnD) |
Research & Development Manager |
Bruker (Group) |
Germany |
Sudarskis, Alexandre (Neovii Pharmaceuticals AG 201707 CEO before Novartis Vaccines) |
Chief Executive Officer (CEO) |
Neopharm (IL) (Group) |
Switzerland |
Sugo, Tsukasa (GenAhead Bio 201810 CEO) |
Chief Executive Officer (CEO) |
GenAhead Bio Inc. (JP) |
Japan |
Sujka, Sebastian (xbird 202101 CEO + Co-Founder) |
Managing Director |
Glooko (Group) |
Germany |
Sullivan, Elaine (Carrick Therapeutics 201501– CEO before Eli Lilly + Evotec 2015H1– Supervisory Board Member) |
Chief Executive Officer (CEO) |
Carrick Therapeutics (Group) |
Ireland, Republic of |
Sullivan, Patrick J. (Consitution Medical Investors 201307 CEO + Co-founder before Cytyc Corp CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Sultan, Maha (King Saud Univ 201112 Professor of Analytical Pharm. Chem.) |
Professor |
King Saud University (KSU) |
Saudi Arabia |
Sulzer, Philipp (Ionicon 201108 Science Manager) |
Researcher (industry) |
Ionicon (Group) |
Austria |
Sumeray (formerly Casse), Anna (Virometix 201902– CEO before Alacrita + BioVault + Ariad Europe + Novartis + ADL) |
Managing Partner |
Alacrita (Group) |
Switzerland |
Summerton, Linda (Immodulon Therapeutics 201702 CEO + TranScrip before Merck KGaA + AstraZeneca) |
Chief Executive Officer (CEO) |
|
|
Sumner, Lloyd (Univ Missouri 201806 Prof at UM at Columbia, MO) |
Professor |
University of Missouri System |
United States (USA) |
Sun, Lanny (Full-Life Technologies 202211 CEO before Silicon Therapeutics 202008 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Full-Life Technologies (Group) |
China |
Sundermann, Martin (Osborne Clarke 201612) |
Attorney / Lawyer |
Osborne Clarke (Group) |
Germany |
Sunesson, Lovisa (Invest in Skane 201111 Business Developer) |
Business Development Manager / Strategy Manager |
Skåne (govt region) |
Sweden |
Superti-Furga, Giulio (Austrian Academy of Sciences 201308 Director fo CeMM + Co-Founder of Proxygen) |
President/Director/Head Business Group/Unit/Division |
Austrian Academy of Sciences (ÖAW) |
Austria |
Supper, Jochen (Genomatix Software 201211 Head Computational Biology) |
n. a. |
Genomatix Software (Group) |
Germany |
Surjo, David (CRS 201307 SVP Business Development + Corproate Administration before Pharm PlanNet GmbH) |
Business Development Manager / Strategy Manager |
CRS Clinical Research Services (Group) |
Germany |
Surya, Arjun (Curadev 202003 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Curadev (Group) |
India |
Susemihl, Kai (Fairtec GmbH 201503 Managing Director + Co-founder) |
Managing Director |
Fairtec Kommunikationstechnik GmbH |
Germany |
Susen, Kathrin (BioPartners Cologne 200505) |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
Suter, Johannes (Helvetica Capital 202101 CEO) |
Chief Executive Officer (CEO) |
Helvetica Capital (CH) |
Switzerland |
Suter, Marc J.-F. (Eawag 201103 + President SGMS) |
President/Director/Head Business Group/Unit/Division |
Eawag (Wasserforschungsinstitut des ETH-Bereichs) |
Switzerland |
Suter-Dick, Laura (Roche 200612 Section Head for New Technologies in Safety) |
n. a. |
Roche (Group) |
Switzerland |
Sutton, Gary (Flagship Pioneering 202007– SVP Corp Development of Pioneering Medicines before NIBR) |
Business Development Manager / Strategy Manager |
Flagship Pioneering |
United States (USA) |
Svahn, Matthias (NextCell Pharma AB 201912 CEO + Co-Founder before Karolinska Institutet + Roche) |
Chief Executive Officer (CEO) |
NextCell Pharma AB |
Sweden |
Svatoš, Aleš (Max Planck 200906 Head of Mass Spectrometry Group at MPI for Chemical Ecology) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
Sveinsson, Andri (Novator Partners 202010 Managing Partner) |
Managing Partner |
Novator Partners (Group) |
United Kingdom (GB) |
Svensson, Samuel (Neogap Therapeutics 202305 CEO) |
Chief Executive Officer (CEO) |
Neogap Therapeutics AB |
Sweden |
Swallow, Mark (Huntsworth 201101 Citigate Dewe Rogerson London Senior Director Life Sciences) |
Public Relations Manager / Investor Relations Manager |
Inizio (Group) |
United Kingdom (GB) |
Swanberg, Greg (BioStorage 201308 CEO) |
Chief Executive Officer (CEO) |
BioStorage (Group) |
United States (USA) |
Swanepoel, Lisa (Bruker 201008 Bruker South Africa + SAAMS) |
n. a. |
|
South Africa |
Swart, Corné (Cellbox Solutions 202109 Executive Director Business Development + Global Sales) |
Business Development Manager / Strategy Manager |
Cellbox Solutions (Group) |
Germany |
Swart, Marius (Pace Ventures Enigma 202202 Managing Director) |
Managing Director |
Pace Ventures Enigma (DE) |
Germany |
Sweeney, John (Millipore 200908– promoted VP Life Science Business Unit joined 2003 as Director Strategy + Corp Dev) |
n. a. |
Merck (DE) (Group) |
United States (USA) |
Sweet, Andrew (Scienion 202006 Managing Director of Scienion UK Ltd) |
Managing Director |
Bico (Group) |
United Kingdom (GB) |
Sweet-Ragan, Nicole (Temedica 202211 VP Marketing) |
Sales Manager / Marketing Manager |
Temedica GmbH |
Germany |
Swieton, Gernot (Ansyco 200801– Managing Director before Prokurist) |
Managing Director |
Ansyco Analytische Systeme und Componenten GmbH |
Germany |
Swindells, Mark (Exscientia 201901 COO) |
Chief Operating Officer (COO) |
Exscientia (Group) |
United Kingdom (GB) |
Sydow, Sabine (Rentschler 202207– Chief of Staff before vfa bio + Schering) |
Human Resources Manager |
Rentschler (Group) |
Germany |
Sykes, Richard (Glaxo-Wellcome) |
Chief Executive Officer (CEO) |
GSK (Group) |
United Kingdom (GB) |
Sykora, Lorenz (Irubis 202005 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Irubis GmbH |
Germany |
Symonds, Bill (Altavant Sciences 202207 CEO) |
Chief Executive Officer (CEO) |
Sumitomo (Group) |
|
Symonds, Jonathan (Novartis 200909–201304 STEPPED DOWN 4/13 before Goldman Sachs + AstraZeneca CFO) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
Szebries, Ruth (Stilla Technologies 201910– General Manager + VP Commercial Americas before Qiagen + BGI + Exiqon) |
General Manager (management) |
Stilla Technologies (Group) |
United States (USA) |
Szillat, Peter (Olympus 200709– Product Manager Immunochemistry) |
n. a. |
Olympus (Group) |
Germany |
Szolar, Oliver (a:head bio 201908– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
red-stars.com data AG |
Austria |
Szolar, Oliver (Savira Pharmaceuticals 201210 CEO before Onepharm) |
Chief Executive Officer (CEO) |
Savira Pharmaceuticals GmbH |
Austria |
Szucs, Thomas D. (BB Biotech 200505) |
n. a. |
Bellevue (Group) |
Switzerland |
Szulczewski, Mike (Bruker Corp 201407 President Fluorescence Microscopy business before Prairie Technologies Founder) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
Sälzle, Martina (Rentschler 201812 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Rentschler (Group) |
Germany |
Söhngen, Mariola (Proteome Sciences 202009– CEO before Convert Pharmaceuticals + Mologen + Paion) |
Chief Executive Officer (CEO) |
Proteome Sciences (Group) |
United Kingdom (GB) |
Söhngen, Wolfgang (Paion 200603 CEO) |
Chief Executive Officer (CEO) |
Humanwell Healthcare (Group) |
Germany |
Söller, Rainer (Anchor Diagnostics GmbH 201508– Managing Director) |
Managing Director |
Anchor Diagnostics GmbH |
Germany |
Sönnichsen, Birte (Cenix BioScience 200902 COO) |
Chief Operating Officer (COO) |
Cenix BioScience (Group) |
Germany |
Söyler, Alper (Onkogen Diagnostik 201202 General Manager) |
General Manager (management) |
Onkogen Diagnostik Sistemler Ltd. Sti. |
Turkey |
Søderberg, Sebastian (Bactolife 202301– CEO formerly Novozymes) |
Chief Executive Officer (CEO) |
Bactolife A/S |
Denmark |
Sørensen, Nikolaj (Orexo 201810 CEO joined 201110 as CCO before Pfizer AB + Boston Consulting Group) |
Chief Executive Officer (CEO) |
Orexo (Group) |
Sweden |
Taapken, Thomas (InflaRx 202010– CFO before Imcyse + Medigene + Epigenomics + Biotie/elbion + DVC + Burrill) |
Chief Executive Officer (CEO) |
InflaRx (Group) |
Netherlands |
Taarnhøj, Frederik (FaunaPhotonics 201612 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
FaunaPhotonics ApS |
Denmark |
Tabernero, Josep (Vall d’Hebron Institute of Oncology 201506 Director) |
President/Director/Head of Research Organisation/Unit |
Vall d’Hebron Institute of Oncology (VHIO) |
Spain (España) |
Tablak, Steve (GeneWeave 201508 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Tada, Yoshiharu (Analytik Jena 2007–201312 Managing Director of AJ Japan RETIRED 12/13) |
Managing Director |
Endress+Hauser (Group) |
Japan |
Taguchi, Ryo (Univ Tokyo 201307 Professor) |
Professor |
University of Tokyo |
Japan |
Taha, Farid (Almirall 201107 Managing Director Germany + Austria + Switzerland) |
Managing Director |
Almirall (Group) |
Spain (España) |
Takagi, Eiji (Altair Corp 201112 President of Acobio KK before President of Biacore KK) |
President/Director/Head Business Group/Unit/Division |
Altair (Group) |
Japan |
Takahashi, Jun (Univ Kyoto 202001 at CiRA) |
Researcher (university / research institute) |
University of Kyoto (Kyoto University) |
Japan |
Takimoto, Chris (Forty Seven 201801 CMO) |
Chief Medical Officer (CMO) |
Forty Seven Inc. |
United States (USA) |
Takino, Toichi (Ono Pharmaceutical 202201 Executive Director Discovery + Research) |
President/Director/Head Business Group/Unit/Division |
Ono Pharmaceutical (Group) |
Japan |
Takke, Christina (V-Bio Ventures 201511 Managing Partner + Co-Founder before Forbion Capital Partners) |
Partner (venture partner) |
V-Bio Ventures |
Belgium |
Talbot, Jonathan (Mosanna Therapeutics 202207 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Mosanna Therapeutics AG |
Switzerland |
Talbot, Michael (Peak Scientific 201304 Territory Manager Germany) |
Sales Manager / Marketing Manager |
Peak Scientific (Group) |
Germany |
Tallett, Elizabeth E. (Hunter Partners 201103 Principal before Transcell Technologies CEO + Centocor President) |
Consultant (economic/technology) |
Hunter Partners LLC |
United States (USA) |
Tamayo, Irene (Lunaphore 201808 Corporate Communications) |
public relations / investor relations |
Bio-Techne (Group) |
Switzerland |
Tamborini, Monica L. (Biofrontera 2015Q1– CEO of newly established US subsidiary) |
Chief Executive Officer (CEO) |
Biofrontera (Group) |
United States (USA) |
Tamiola, Kamil (Peptone 201804– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Peptone (Group) |
United Kingdom (GB) |
Tamir, Ronen (Rosetta Genomics 200712– Exec VP Marketing + Communication before Novartis VP Investor Relations NA) |
Sales Manager / Marketing Manager |
Rosetta Genomics (Group) |
Israel |
Tamkivi, Sten |
n. a. |
|
|
Tamminen, Manu (Genomill Health 201912 CTO) |
Chief Technology/Technical Officer (CTO) |
Genomill Health (FI) |
Finland |
Tan, Ben T.G. (ObsEva 201409– VP Commercial + BusDev before Evolva + Novartis/Speedel + Organon + Roche) |
Business Development Manager / Strategy Manager |
ObsEva (Group) |
Switzerland |
Tan, Choon Shian (Singapore (govt) 201104 Deputy Managing Director EDB) |
Managing Director |
Singapore (govt) |
Singapore |
Tanaka, Hiroaki (Debiopharm 201305 Director of Personalized Medicine) |
Research & Development Manager |
Debiopharm (Group) |
Switzerland |
Tanaka, Satoshi (Actelion 201204 President of Actelion Japan + South Korea) |
President/Director/Head Business Group/Unit/Division |
Johnson & Johnson (JnJ) (Group) |
Japan |
Tang, Lili (Schauenburg 201709– General Manager at Markes Instruments (Shanghai) Co Ltd) |
General Manager (management) |
Schauenburg (Group) |
China |
Tangermann, Pierre (PerioTrap Pharmaceuticals 201901– Managing Director) |
Managing Director |
PerioTrap Pharmaceuticals GmbH |
Germany |
Tannenbaum, Renee P. (Nordic Nanovector 201605– Board Member before AbbVie + Èlan + Novartis + BMS) |
Board member |
Nordic Nanovector (Group) |
Norway |
Tanner, Chris (Cassiopea 201507 CFO + Head of Investor Relations + Cosmo Pharmaceuticals CFO + Head IR before UBS) |
Chief Financial Officer (CFO) |
Cassiopea S.p.A. (SIX: SKIN) |
Italy |
Tapp, Ashley (Consilium Strategic Communications 202104 before Instinctif Partners) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
United Kingdom (GB) |
Tappy, Damien (Endeavour Vision 202104 Managing Partner + President) |
Managing Partner (investment firm) |
Endeavour Vision (Group) |
Switzerland |
Tardif, Paul (Waters 201806 Senior Director Corp Development) |
Business Development Manager / Strategy Manager |
Waters (Group) |
United States (USA) |
Tarlach, Stephan (bmp 200503) |
n. a. |
bmp (Group) |
Germany |
Tarnovskiy, Andrey (Enamine 202305–Sales Director Europe) |
Sales Manager / Marketing Manager |
Enamine Ltd. (UA) |
Ukraine |
Tarr, Ian J. (Current BioData 200610– CEO before Thomson Scientific before Current Drugs Ltd) |
Chief Executive Officer (CEO) |
Science Navigation Group |
Switzerland |
Tasaka, Masao (NAIST 2010 Professor within Plant Science Global Top Education Program) |
Professor |
Nara Institute of Science and Technology (NAIST) |
Japan |
Tascione, Roberto (Zambon 201907 CEO) |
Chief Executive Officer (CEO) |
Zambon (Group) |
Italy |
Tasker, Tim (Heptares 201401– CMO before own consulting firm before Evotec + GSK) |
Chief Medical Officer (CMO) |
Evotec (Group) |
Germany |